An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain

Clinical trial NCT00385671 · COMPLETED

Trial details

NCT number: NCT00385671
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetic Neuropathy, Painful

Start date: 2006-09-01
Primary completion: 2009-08-01
Enrollment: 407

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.